ClinicalTrials.Veeva

Menu

Overal Survival After TAVI According to Sarcopenia (TAVI_Sarx)

N

Nemocnice AGEL Trinec-Podlesi a.s.

Status

Completed

Conditions

Aortic Valve Stenosis
Sarcopenia

Treatments

Diagnostic Test: CT evaluated sarcopenia

Study type

Observational

Funder types

Other

Identifiers

NCT05672160
TAVI_Sarx

Details and patient eligibility

About

The goal of this observational study is to compare the overal survival after transcatheter aortic valve implantation (TAVI) according to sarcopenia status evaluated from preprocedural CT scans.

The main question it aims to answer is:

• Is CT evaluated sarcopenia an independent predictor of overal survival after TAVI?

Full description

The patients suffering from aortic valve stenosis, that are not eligible for cardiosurgery were indicated to miniinvasive transcatheter aortic valve implantation (TAVI). The follow up of 930 patients were done in time interval from 1 to 11 years. In every patient the preprocedural CT scans were done. From these CT scans the L3 cross sections will be used for sarcopenia evaluation. Then we will statisticaly evaluate the overal survival after TAVI procedure in the relation with sarcopenia status. We will answer the main question: Is CT evaluated sarcopenia an independent predictor of overal survival after TAVI?

Enrollment

930 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients udergone TAVI procedure

Exclusion criteria

  • patients with incomplete TAVI procedure, patients without clinical follow up

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems